LGNDLigand Pharmaceuticals, Inc. - Ordinary Shares - Class B
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B2,589
Mkt Cap
$4.65BVolume
185,398.0052W High
$247.3852W Low
$98.89PE Ratio
39.86LGND Fundamentals
Price
$232.55Prev Close
$232.30Open
$235.0950D MA
$213.08Beta
1.02Avg. Volume
224,969.93EPS (Annual)
$6.13P/B
4.52Rev/Employee
$5.7M$3,554.96
Insider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Insider Sells 5,000 Shares of Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) insider Andrew Reardon sold 5,000 shares of the business's stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $231.31, for a total transaction of $1,156,550.00. Following the completion of the...
MarketBeat·2d ago
Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Kornitzer Capital Management Inc. KS
Kornitzer Capital Management Inc. KS lessened its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 33.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 60,342 shares of the biotechnology compan...
MarketBeat·5d ago
HC Wainwright Brokers Increase Earnings Estimates for LGND
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) - Stock analysts at HC Wainwright lifted their Q3 2026 earnings per share estimates for Ligand Pharmaceuticals in a research note...
MarketBeat·6d ago
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Consensus Rating of "Moderate Buy" from Analysts
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) has earned an average rating of "Moderate Buy" from the eight brokerages that are currently covering the company, Marketbeat...
MarketBeat·6d ago
HC Wainwright Issues Positive Forecast for Ligand Pharmaceuticals (NASDAQ:LGND) Stock Price
HC Wainwright boosted their target price on Ligand Pharmaceuticals from $243.00 to $289.00 and gave the company a "buy" rating in a research report on Thursday...
MarketBeat·7d ago
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Gap Down - Here's Why
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Gap Down - What's Next...
MarketBeat·8d ago
Moody Aldrich Partners LLC Has $3.70 Million Stock Holdings in Ligand Pharmaceuticals Incorporated $LGND
Moody Aldrich Partners LLC decreased its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 24.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 19,581 shares of the biotechnology company's stock after selling 6,303 sha...
MarketBeat·8d ago
Royal Bank Of Canada Issues Positive Forecast for Ligand Pharmaceuticals (NASDAQ:LGND) Stock Price
Royal Bank Of Canada lifted their price target on shares of Ligand Pharmaceuticals from $235.00 to $252.00 and gave the company an "outperform" rating in a research report on Tuesday...
MarketBeat·9d ago
Ligand Pharmaceuticals to Buy XOMA Royalty for $39/Share, Lifts 2026 Guidance and EPS Outlook
Ligand Pharmaceuticals (NASDAQ:LGND) detailed plans to acquire XOMA Royalty Corporation in an investor call, outlining what executives described as a highly complementary transaction intended to...
MarketBeat·9d ago
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation PR Newswire NEW YORK...
PR Newswire·10d ago
<
1
2
...
>